Vanda Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Vanda Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Vanda Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 58.3M shares, a 1.38% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 58.3M +790K +1.38% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 58.2M +756K +1.32% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 57.5M +751K +1.32% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 57.5M +941K +1.66% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 57.5M +944K +1.67% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 57.4M +954K +1.69% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 56.8M +883K +1.58% Dec 31, 2022 10-K 2024-02-08
Q3 2022 56.6M +880K +1.58% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 56.6M +925K +1.66% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 56.5M +926K +1.67% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 55.9M +1.04M +1.89% Dec 31, 2021 10-K 2023-02-09
Q3 2021 55.7M +1.02M +1.86% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 55.6M +999K +1.83% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 55.6M +1.43M +2.64% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 54.9M +1.32M +2.46% Dec 31, 2020 10-K 2022-02-24
Q3 2020 54.7M +1.36M +2.54% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 54.6M +1.36M +2.56% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 54.1M +1.17M +2.21% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 53.5M +1.07M +2.04% Dec 31, 2019 10-K 2021-02-11
Q3 2019 53.3M +933K +1.78% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 53.3M +889K +1.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 53M +853K +1.64% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 52.5M +7.54M +16.8% Dec 31, 2018 10-K 2020-02-26
Q3 2018 52.4M +7.48M +16.6% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 52.4M +7.53M +16.8% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 52.1M +7.56M +17% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 44.9M +938K +2.13% Dec 31, 2017 10-K 2019-02-19
Q3 2017 44.9M +992K +2.26% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 44.8M +1.56M +3.61% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 44.5M +1.44M +3.33% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 44M +1.19M +2.77% Dec 31, 2016 10-K 2018-02-15
Q3 2016 43.9M +1.12M +2.61% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 43.3M +1.01M +2.39% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 43.1M +1.32M +3.15% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 42.8M +1.33M +3.2% Dec 31, 2015 10-K 2017-02-17
Q3 2015 42.8M +8.91M +26.3% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 42.3M +8.39M +24.8% Jun 30, 2015 10-Q 2015-07-31
Q1 2015 41.8M +7.92M +23.4% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 41.5M +8.15M +24.4% Dec 31, 2014 10-K 2016-02-12
Q3 2014 33.9M +711K +2.14% Sep 30, 2014 10-Q 2014-10-27
Q2 2014 33.9M +5.39M +18.9% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 33.9M +5.53M +19.5% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 33.3M +5.1M +18% Dec 31, 2013 10-K 2015-03-13
Q3 2013 33.2M +4.96M +17.6% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 28.5M +256K +0.91% Jun 30, 2013 10-Q 2013-07-31
Q1 2013 28.3M +120K +0.43% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 28.2M +125K +0.44% Dec 31, 2012 10-K 2014-02-25
Q3 2012 28.2M +116K +0.41% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 28.2M +123K +0.44% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 28.2M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 28.1M +75.6K +0.27% Dec 31, 2011 10-K 2013-02-26
Q3 2011 28.1M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 28.1M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 28M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.